Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00334802
What this trial is testing

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 62
Large-scale testing (Phase 3)Study completedNCT01827553
What this trial is testing

Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Who this might be right for
Pancreatic Cancer
University of Erlangen-Nürnberg Medical School 830
Not applicableUnknownNCT03559803
What this trial is testing

A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

Who this might be right for
Cervical Cancer
Sichuan University 58
Not applicableUnknownNCT03958435
What this trial is testing

Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery

Who this might be right for
Stage II Colon CancerStage III Colon CancerAdjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 20,000
Testing effectiveness (Phase 2)Study completedNCT02046733
What this trial is testing

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
ETOP IBCSG Partners Foundation 222
Large-scale testing (Phase 3)Ended earlyNCT02927249
What this trial is testing

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Who this might be right for
Node Positive HER2 Negative Breast Cancer
Alliance for Clinical Trials in Oncology 3,021
Not applicableUnknownNCT06241833
What this trial is testing

Emulation of Randomized Clinical Trial in Cardiovascular Disease

Who this might be right for
Myocardial InfarctionCoronary Artery Disease
Samsung Medical Center 118,420
Not applicableNot Yet RecruitingNCT07499882
What this trial is testing

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Christian Hospital Northeast Northwest 24
Large-scale testing (Phase 3)UnknownNCT02354313
What this trial is testing

Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients

Who this might be right for
MANTLE CELL LYMPHOMA
Fondazione Italiana Linfomi - ETS 300
Large-scale testing (Phase 3)Looking for participantsNCT07502820
What this trial is testing

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

Who this might be right for
Breast CancerAdjuvant Drug Therapy
Karolinska Institutet 1,100
Testing effectiveness (Phase 2)Study completedNCT00003237
What this trial is testing

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 55
Testing effectiveness (Phase 2)Ended earlyNCT04675827
What this trial is testing

De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

Who this might be right for
HER2-positive Breast CancerER-Negative Breast CancerPR-Negative Breast Cancer+1 more
Jules Bordet Institute 139
Testing effectiveness (Phase 2)Ended earlyNCT00479856
What this trial is testing

Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer

Who this might be right for
Relapsed Breast CancerNeoplasms, Breast
GlaxoSmithKline 9
Early research (Phase 1)Study completedNCT00000920
What this trial is testing

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)UnknownNCT01270373
What this trial is testing

NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After?

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil 112
Post-approval studies (Phase 4)Active Not RecruitingNCT04961190
What this trial is testing

A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

Who this might be right for
Posttraumatic Stress Disorder
University of Pennsylvania 304
Testing effectiveness (Phase 2)Looking for participantsNCT03351842
What this trial is testing

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Who this might be right for
Chemotherapy, AdjuvantLung Adenocarcinoma, Stage ITreatment+1 more
Shanghai Pulmonary Hospital, Shanghai, China 460
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754123
What this trial is testing

Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Hansoh Pharmaceutical Co., Ltd. 206
Testing effectiveness (Phase 2)UnknownNCT02350686
What this trial is testing

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 67
Not applicableStudy completedNCT05024331
What this trial is testing

A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor

Who this might be right for
Pediatric Solid Tumor
Samsung Medical Center 10
Next Page